跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACH-ESCITALOPRAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACH-ESCITALOPRAM
Authorized
STANDARD
ACH-ESCITALOPRAM
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cce26d9f8e244fe5
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
cce26d9f8e244fe5
Drug Approval Canada Name
ACH-ESCITALOPRAM
Product Name
ACH-ESCITALOPRAM
Status
Marketed
Status Date
2016-06-10
Original Market Date
2016-06-10
Din
02434652
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB10 ESCITALOPRAM
Atc Name
n 06 ab 10
Aig Number
0150435002
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Active Ingredients
ESCITALOPRAM (ESCITALOPRAM OXALATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cce26d9f8e244fe5
Type
Standard
Back to Health Canada Approvals